Phthalazine

Overview

Phthalazine is a chemical scaffold. Phthalazine derivatives act as VEGFR-2 inhibitors, PARP-1 inhibitors, and anticancer agents. The complex of phthalazine with silver exhibits broad-spectrum antibacterial and antifungal activities against Staphylococcus aureus , Enterococcus faecalis , Escherichia coli , Pseudomonas aeruginosa PAO1, and Candida albicans . Phthalazine derivatives possess potent vasodilatory activity. Phthalazine can be used in research related to colon adenocarcinoma, breast cancer , hypertension, diabetes, and microbial infections.

Application

Products | Products > Disease Areas > Bacterial Infection | Products > Disease Areas > Fungal Infection | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Colorectal Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Staphylococcus Aureus Infection | Products > Disease Areas > Escherichia Coli Infection | Products > Disease Areas > Pseudomonas Aeruginosa Infection | Products > Disease Areas > Candida Infection | Products > Disease Areas > Type 1 Diabetes | Products > Disease Areas > Hypertension | Products > Disease Areas > Type 2 Diabetes | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Digestive System Disease | Products > Signaling Pathways > Others | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Infection | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Drug Intermediate

Product Information

• Catalog No.: HY-W002016
• CAS No.: 253-52-1
• Molecular Formula: C8H6N2
• Molecular Weight: 130.15
• Purity: 99.98%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 5 mg/mL (38.42 mM); Clear solution
• Availability: In-stock

Source

Original product source